Industry Programs are a promotional activity and are not approved for continuing education credit unless otherwise noted. The content and opinions expressed by presenters are those of the sponsor or presenter and are not supported, endorsed, or accredited by the American Thoracic Society.
Browse Event Schedules by Type:
Featured
“I Want to Breathe Better”: Help Appropriate Uncontrolled Asthma and COPD Patients
Innovation Theater 4
Sponsored by: Sanofi | Regeneron
Closing the Gap: Improving Diagnosis in the U.S. Cystic Fibrosis Population
Innovation Theater 1
Sponsored by: Vertex Pharmaceuticals, Inc.
Cracking the Case: Interactive Insights on Collaborative Care in Interstitial Lung Disease Diagnosis
Innovation Theater 3
Sponsored by: Boehringer Ingelheim Pharmaceuticals, Inc.
Expanding Our Understanding of COPD: The Role of IL-33 in Chronic Airway Inflammation
Hyatt SOMA – Gallery Ballroom 1-3
Sponsored by: Sanofi
Supported by: Individual educational grants from Sanofi | Regeneron
Managing Upper and Lower Airway Diseases: The Role of Epithelial-Driven Inflammation
Marriot Marquis – Golden Gate Ballroom A/B
Sponsored by: National Jewsish Health
Eosinophils in COPD: A Biomarker of Type 2 Inflammation to Predict Therapeutic Response
Innovation Theater 4
Sponsored by: Sanofi | Regeneron
Clearing the Air on Bronchiectasis Exacerbations: Burden, Causes, and Management of Exacerbations
Innovation Theater 3
Sponsored by: Insmed Incorporated
Everyday Essentials: ILD Resources for Learning
Innovation Hub 6
Sponsored by: Boehringer Ingelheim Pharmaceuticals, Inc.
Treating the Whole Patient: Is Controlling Exacerbations Doing Enough in Asthma and COPD?
Hyatt SOMA, Gallery Ballroom 1-3
Sponsored by: Sanofi | Regeneron
Bridging the Gap: Understanding Interstitial Lung Disease (ILD) from a Physician and Patient Perspective
Marriott San Francisco Marquis – Golden Gate Ballroom A/B
Sponsored by: Boehringer Ingelheim Pharmaceuticals, Inc.
Many Paths, One Goal: Collaborative COPD Care for Patients with Type 2 Inflammation
Innovation Theater 3
Sponsored By: GSK
Breathing New Life: Inhaled Nintedanib and the Future of Pulmonary Fibrosis Treatment
Innovation Theater 2
Sponsored by: Avalyn Pharma
Evolving Our View of COPD: Sounding the Alarm on Chronic Inflammation
Innovation Theater 2
Sponsored by: Sanofi | Regeneron